New asthma inhaler passes first safety check in healthy volunteers
NCT ID NCT06916273
First seen Jan 04, 2026 · Last updated May 12, 2026 · Updated 23 times
Summary
This early-stage study tested a new asthma inhaler called PA9159 in 40 healthy adults in China. The goal was to see if it is safe and how the body processes it, not to treat asthma. Participants took single and repeated doses, and researchers monitored side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIAL ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
Conditions
Explore the condition pages connected to this study.